Methylation in cornea and corneal diseases: a systematic review

Yutong Xia,Kuangqi Chen,Qianjie Yang,Zhitong Chen,Le Jin,Liyue Zhang,Xin Yu,Liyin Wang,Chen Xie,Yuan Zhao,Ye Shen,Jianping Tong

DOI: https://doi.org/10.1038/s41420-024-01935-2

2024-04-09

Cell Death Discovery

Abstract:Corneal diseases are among the primary causes of blindness and vision loss worldwide. However, the pathogenesis of corneal diseases remains elusive, and diagnostic and therapeutic tools are limited. Thus, identifying new targets for the diagnosis and treatment of corneal diseases has gained great interest. Methylation, a type of epigenetic modification, modulates various cellular processes at both nucleic acid and protein levels. Growing evidence shows that methylation is a key regulator in the pathogenesis of corneal diseases, including inflammation, fibrosis, and neovascularization, making it an attractive potential therapeutic target. In this review, we discuss the major alterations of methylation and demethylation at the DNA, RNA, and protein levels in corneal diseases and how these dynamics contribute to the pathogenesis of corneal diseases. Also, we provide insights into identifying potential biomarkers of methylation that may improve the diagnosis and treatment of corneal diseases.

cell biology

What problem does this paper attempt to address?

The problem this paper attempts to address is that the pathogenesis of corneal diseases is not yet clear, and diagnostic and therapeutic tools are limited. Therefore, identifying new diagnostic and therapeutic targets has become particularly important. Methylation, as an epigenetic modification, plays a key role in various cellular processes, including the regulation of nucleic acids and protein levels. Increasing evidence suggests that methylation plays a critical role in the pathogenesis of corneal diseases, particularly in aspects such as inflammation, fibrosis, and neovascularization, making it an attractive potential therapeutic target.

Specifically, this paper aims to explore the following questions:
1. What are the major changes in methylation and demethylation at the DNA, RNA, and protein levels in corneal diseases? How do these dynamic changes affect the pathogenesis of corneal diseases?
2. Are there potential biomarkers related to methylation that can enhance the diagnosis and treatment of corneal diseases?

By systematically reviewing existing studies, this paper summarizes the role of methylation in corneal diseases, emphasizes the importance of DNA, RNA, and histone methylation, and provides new insights into the methylation-related pathogenesis of corneal diseases, with the aim of offering new perspectives for treatment.